Akcea Therapeutics Inc buy melinda
Start price
31.08.18
/
50%
?23.99
Target price
24.09.18
€28.86
Performance (%)
20.64%
End price
24.09.18
€28.95
Summary
This prediction ended on 24.09.18 with a price of €28.95. The BUY prediction by melinda finished with a performance of 20.64%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Akcea Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
| iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
| iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
| iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by melinda for this prediction
In the thread Akcea Therapeutics Inc diskutieren
SecteurProduits pharmaceutiques Agenda 05/11 Publication de résultats
Akcea Therapeutics, Inc. is a late-stage pharmaceutical company, which engages in the development and commercializing of drugs fro the treatment of cardio metabolic diseases caused by lipid disorders.
Its products include novel drugs under the followng brands: volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx.
The company was founded in December 2014 and is headquartered in Cambridge, MA.
Nombre d'employés : 100 personnes.
Stopped prediction by melinda for Akcea Therapeutics Inc
Akcea Therapeutics Inc
Start price
Target price
Perf. (%)
?28.85
22.03.18
22.03.18
€31.57
02.08.18
02.08.18
10.85%
02.08.18
02.08.18
Akcea Therapeutics Inc
Start price
Target price
Perf. (%)
?15.15
28.02.18
28.02.18
€29.77
19.03.18
19.03.18
76.79%
19.03.18
19.03.18
Akcea Therapeutics Inc
Start price
Target price
Perf. (%)
?16.68
23.10.17
23.10.17
€26.61
05.02.18
05.02.18
15.47%
05.02.18
05.02.18
Akcea Therapeutics Inc
Start price
Target price
Perf. (%)
?19.84
09.09.17
09.09.17
€21.65
15.09.17
15.09.17
10.00%
15.09.17
15.09.17
Akcea Therapeutics Inc
Start price
Target price
Perf. (%)
?21.99
09.09.17
09.09.17
€24.00
15.09.17
15.09.17
10.00%
15.09.17
15.09.17